The objectives of this study were to determine how variable stool consistency is in patients with irritable bowel syndrome (IBS) and to assess the relationship between stool consistency and gastrointestinal symptoms.
INTRODUCTION
Patients with irritable bowel syndrome (IBS) are subtyped into those with predominant diarrhea (IBS-D), predominant constipation (IBS-C), mixed or alternating bowel habits (IBS-M), and those with no signifi cant abnormalities in their stools (IBS-U) ( 1 ) . Th e assignment of IBS patients to the appropriate subtype is critical to management because pharmacological treatments for IBS are designed to address either constipation or diarrhea as a means of improving the multiple symptoms of IBS. Lubiprostone ( 2 ), linaclotide ( 3 ) , and tegaserod ( 4 ) were developed to treat IBS-C, whereas alosetron ( 5 ) was developed to treat IBS-D, and the use of these drugs in a subtype of IBS diff erent from the one it was developed for is thought to place the patient at risk for worsening bowel symptoms. Th us, it is important to know whether patients can be reliably classifi ed into these subtypes and whether the subtypes are stable over time. Previous studies suggest, however, that IBS subtype classifi cation is not stable: half ( 6 ) to ¾ of IBS patients ( 7, 8 ) change their subtype classifi cation over a 1-year period. Most of these transitions are between IBS-C and IBS-M or between IBS-D and IBS-M, with relatively few patients transitioning between IBS-D and IBS-C ( 7 ). Th is degree of instability raises concerns about the reliability of treatment guidelines based on IBS subtype and suggests that more data are needed on within-subject variability in stool consistency and the relationship between variations in stool consistency and other symptoms of IBS such as pain and bloating.
IBS Patients Show Frequent Fluctuations Between
Limited data are available on the relationship of stool consistency to other IBS symptoms, and the fi ndings are oft en inconsistent. Hellstrom et al. ( 9 ) reported that pain episodes are more closely associated with loose / watery stools than with hard / lumpy stools, although Ragnarsson and Bodemar ( 10 ) found no relationship between abdominal pain and defecation. Chang et al. ( 11 ) reported that abdominal distention is more strongly associated with IBS-C than with IBS-D, whereas the subjective sensation of bloating without distention is more closely associated with diarrhea; they found that defecation or passing gas relieved both bloating and distention. Other investigators, however, fi nd no association between bowel habits and either distention or bloating ( 12 ) . Urgency is more closely associated with diarrhea than with constipation ( 13 ) .
Th e primary aims of this 90-day diary study were to (i) characterize the bowel-movement-to-bowel movement (BM-to-BM) and day-to-day variability in stool consistency for IBS patients and (ii) describe the association of abnormal stool consistency and IBS subtype with other gastrointestinal symptoms and the interference of abnormal stool consistency in the patient ' s life. A secondary aim was to determine whether the Rome III classifi cation of IBS patients into IBS-C, IBS-M, and IBS-D subtypes by retrospective questions is confi rmed by prospective diary data.
METHODS
Individuals with IBS aged ≥ 18 years were enrolled through advertising to complete 90 days of diary recordings of their bowel movements (BWs) and gastrointestinal symptoms. Th e study was advertised on the website of the Center for Functional GI & Motility Disorders at UNC, Chapel Hill, on national websites frequented by IBS patients (such as www.IFFGD.org and www. IBSgroup.org ), and through mass e-mails to staff , students, and faculty at UNC, Chapel Hill. Additionally, IBS patients who had registered to participate in research studies in our Center were invited to participate.
Inclusion criteria in the study were age of at least 18 years (no upper limit), daily access to the internet, fulfi lling Rome III criteria for IBS ( 1 ) , and having been diagnosed with IBS by a physician. Exclusion criteria were a history of infl ammatory bowel disease, celiac disease, or lactose intolerance, daily use of IBS prescription medications (lubiprostone, tegaserod, or alosetron), and current participation in pharmacologic trials. Subjects were permitted to use antidiarrheal or laxative medications or antidepressants occasionally, but were asked to refrain from using these drugs as much as possible during the study and to record when they used them in their symptom diary.
A total of 595 potential subjects were screened online for participation in the study, out of which 392 met study criteria and were invited to enroll through the mail. Th e mailing contained (i) the study consent form and a physician release of information form for verifying IBS diagnosis, both of which the subjects were instructed to sign and return via mail; (ii) the printed pocket diary for recording BWs and associated symptoms; and (iii) instructions and a password for accessing the secure study website to enter study data.
Before beginning to record their bowel symptoms in the diary, subjects completed the Rome III Diagnostic Questionnaire ( 14 ), the IBS Severity Scale (IBS-SS) ( 15 ) , the IBS Quality of Life questionnaire (IBS-QOL) ( 16, 17 ) , and the Brief Symptom Inventory 18 (BSI-18) ( 18 ), which is a psychological symptom questionnaire.
Th e Rome III Diagnostic Questionnaire ( 14 ) includes two questions that are used to determine IBS subtype. One question asks, " In the last 3 months, how oft en did you have hard or lumpy stools? " and the other asks, " In the last 3 months, how oft en did you have loose, mushy, or watery stools? " Th e standard response choices are 0 = " Never or rarely " ; 1 = " Sometimes " ; 2 = " Oft en " ; 3 = " Most of the time " ; and 4 = " Always " ; although investigators are given the option of substituting a diff erent response scale in which 0 = " Never or rarely " ; 1 = " About 25 % of the time " ; 2 = " About 50 % of the time " ; 3 = " About 75 % of the time " ; and 4 = " Always, 100 % of the time. " In this study the standard response scale was used and a response of " Sometimes " was treated as equivalent to 25 % of BMs.
Th e IBS-SS questionnaire ( 15 ) consists of 5 equally weighted questions about IBS symptoms in the past 10 days. Th e average severity of abdominal pain, average severity of bloating, dissatisfaction with bowel habits, and interference of symptoms with activities of daily life are queried on 0 -100 mm visual analog scales. A fi ft h question asks about the number of days of abdominal pain in the past 10 days, and the response is multiplied by 10 to give this question the same weight as the other 4.
Aft er completing these baseline questionnaires, subjects began the 90-day diary recording period in which they reported on every BM throughout each day in a pocket-sized diary notebook. Th ey rated the stool consistency of each BM on the 7-point Bristol Stool Scale ( 19 ) by referring to pictures and verbal descriptors in their diary book, and reported (yes / no) any associated symptoms of urgency, pain, or fecal soiling. Each night, the subjects were asked to transfer their diary ratings for that day to a secure website, where they also rated on a 0 -10 scale their global 24-h symptoms of abdominal pain, bloating, dissatisfaction with their BMs, and life interference from bowel symptoms (the same symptoms included in the IBS-SS ( 15 ) questionnaire), and life stress. Th ey were also asked to report any medications used during the day. If subjects failed to complete the online diary on any given day, they were reminded to do so by study staff the next day via e-mail. Th ey could then enter their data for the previous day, but were only allowed to enter data for one retrospective day. If subjects missed more than 3 days of diary recordings, their participation was terminated.
FUNCTIONAL GI DISORDERS
Palsson et al .
Th e study participants were paid $ 1 for each diary day they completed to compensate them for their time and eff ort, and they also received an additional bonus of $ 30 for every 30 days of the total 90-day diary period that they completed without interruptions. Th e study was reviewed and approved by the Biomedical Institutional Review Board at the University of North Carolina at Chapel Hill.
Data analysis
Data from all subjects who completed a minimum continuous diary record period of at least 21 days were analyzed. Th is resulted in an analysis sample of 185 patients. For each patient record analyzed, only the single longest continuous stretch of diary days was selected for analysis; i.e., no interrupted date sequences were used in the analyses. Th e average length of the continuous diary records submitted to analysis was 72.9 days (median 86 days, range 21 -106 days; a few subjects continued diary data entry longer than the required 90 days). Th e diary periods analyzed contained an average of 133.2 consecutive BMs.
To characterize BM-to-BM and day-to-day variability in stool consistency (aim 1), we calculated the proportion of BMs and days with each stool consistency in the whole group of 185 IBS patients. To address the secondary aim -validation of the Rome classifi cation of IBS patients into subtypes -we compared the IBS subtypes assigned based on the diary data to the subtypes based on the Rome III Diagnostic Questionnaire completed at enrollment. In both cases, patients were classifi ed as IBS-D if they had ≥ 25 % loose / watery BMS and < 25 % hard / lumpy BMS; IBS-C if they had < 25 % loose / watery BMs and ≥ 25 % hard / lumpy BMs; IBS-M if they had ≥ 25 % loose / watery BMs and ≥ 25 % hard / lumpy BMs; and IBS-U if they had < 25 % loose / watery and < 25 % hard / lumpy BMs. Patients who took laxatives or antidiarrheal medications were excluded from this analysis. To investigate the relationship between stool consistency and gastrointestinal symptoms such as pain and bloating, we fi rst examined the associations between these symptoms and stool types in the pooled sample of all 185 IBS patients. Next we compared symptom severity in IBS subtypes defi ned by the Rome III Diagnostic Questionnaire.
A separate analysis was performed to assess the stability of bowel habits and IBS symptoms by comparing the fi rst and second 30-day periods of diary records for the same subject. Th is analysis was limited to the 135 subjects who had at least 60 days of uninterrupted diary entries. For this analysis, the IBS-SS index was computed based on the diary data as follows: for daily questions on abdominal pain severity, bloating severity, dissatisfaction with bowel habits, and interference with activities of daily life, the average severity score for the 30-day period was used in the computation of the IBS-SS, and the proportion of days with any pain was multiplied by 100.
Two post hoc analyses were performed to follow-up on the paradoxical fi nding that, on average, IBS-C patients had more severe symptoms of pain, bloating, bowel habit dissatisfaction, and life interference than IBS-D patients, although when individual BMs were compared with each other, loose / watery stools triggered more intense symptoms than hard / lumpy or normal-consistency stools. Th e fi rst analysis was an analysis of variance comparing IBS subtypes on days without any BM, and the second analysis compared pain and bloating by paired t -tests on cumulative days of constipation (hard / lumpy stools or no BM) for patients with IBS-C.
Th e χ 2 tests were used to compare subgroups on categorical variables. Analysis of variance tests with Bonferroni-adjusted post hoc tests were used to compare mean scores on continuous variables between and within subgroups. Correlations between variables were assessed by the Spearman nonparametric correlation coeffi cient.
RESULTS

Subject characteristics
Of the 392 subjects who met inclusion criteria and were invited to participate in the study, 206 (52.5 % ) enrolled and started diary entries. Nonparticipants were not signifi cantly diff erent from participants with respect to age, sex, or frequency of self-reported bowel symptoms (abdominal pain, loose / watery stools, or hard / lumpy stools in the past 3 months) on screening questionnaires. Seven enrolled subjects dropped out aft er beginning the diary recordings, and fi ve others were dismissed because of low compliance with diary entries. Another nine subjects completed the 3-month study but were not included in the data analysis because their diary records did not meet the criterion of 21 consecutive days of complete data.
Average age of the 185 patients included in the analyses for this study was 36.6 years (range 19 -70) . Th e sample was 88.6 % females (164 / 185). Th e Rome III IBS subtype distribution based on the Rome III Diagnostic Questionnaire ( 18 ) was 31.9 % IBS-D, 55.1 % IBS-M, and 12.4 % IBS-C. Only one subject (0.5 % ) had IBS-U. Self-described races of participants were 94.1 % Caucasian, 2.7 % African American, 0.5 % Asian, and 2.7 % mixed race. Age and race were equivalent between bowel subtype groups ( Table 1 ), but sex distribution was not ( χ 2 = 0.007): the IBS-D subgroup had a higher proportion of males than IBS-C or IBS-M.
Th e average IBS Severity Score on retrospective questionnaires completed at enrollment was 248.6, which is in the moderate range according to published guidelines for this scale ( 15 ): 23.2 % had scores in the mild range ( ≤ 175), 42.7 % in the moderate range ( > 175 and < 300), and 34.1 % in the severe range ( ≥ 300). Th e IBS-D, IBS-M, and IBS-C subgroups had equivalent mean scores on both overall IBS severity and the individual bowel symptoms measured by the IBS-SS at screening, and they did not diff er signifi cantly in either the quality of life or psychological distress or life stress ratings ( Table 1 ) .
Medication use
Of the total analysis sample of 185 individuals, 28 (15.1 % ) used antidiarrheal medications during the study, 25 (13.5 % ) used laxatives, and 2 (1.1 % ) used both. Eleven subjects reported using antidepressants at least once but 45 did not respond to this question. During the diary recording period, 130 subjects (70.3 % ) used neither laxatives nor antidiarrheal medications.
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Distribution of stool consistency ratings across bowel movements
In the total sample of 185 IBS patients, the majority (58.1 % ) of BMs received Bristol Stool Scale ratings of 3 -5, which defi ne the normal range. Loose / watery stools and hard / lumpy stools were about equally represented (20.5 % and 21.2 % , respectively). Average stool frequency was 1.80 per day.
To ensure that the use of laxatives or antidiarrheal medications by 30 % of the patients in the study did not bias this general characterization of stool consistency patterns in IBS, we repeated the analysis of stool consistency ratings across BMs aft er excluding all patients who reported using antidiarrheal medications or laxatives. Th is changed the results very little: 59.3 % of BMs were of normal consistency, 20.4 % were loose / watery, and 20.3 % were hard / lumpy. Average stool frequency was 1.79 BMs / day in those taking no laxatives or antidiarrheal medications.
Fluctuations between loose / watery stools (Bristol Stool Scores of 6 or 7) and hard / lumpy stools (Bristol Stool Scores of 1 or 2) were common even among patients who took no laxatives or antidiarrheal medications. In this group of 130 individuals, only 13 (10 % ) had no loose / watery stools in their diary records, and only 17 (13.1 % ) had no hard / lumpy stools. Fluctuations between loose / watery and hard / lumpy stools occurred in 77.7 % of these patients, and all patients averaged 2.98 fl uctuations per 30 days (range 0 -15.51).
Although most subjects showed a mixture of stool types, they showed distinct individual patterns that were stable from the fi rst month to the second month. (Th e third month was not included in this analysis because many subjects did not complete 3 full months of uninterrupted data). As shown in Table 2 , the proportion of BMs rated loose / watery correlated 0.783 between the fi rst and second months, and the proportion of BMs rated hard / lumpy correlated 0.852 between the fi rst and second months. Symptoms of pain, bloating, bowel habit dissatisfaction, and life interference were also highly correlated between the fi rst and second months.
Distribution of stool consistency ratings across days
Th e questions used to subtype IBS patients as IBS-D, IBS-C, or IBS-M usually ask about the proportion of BMs that are loose / watery and the proportion of BMs that are hard / lumpy. However, this could misrepresent usual bowel habits if loose / watery BMs tend to cluster together, occurring multiple times a day for a few days with such clusters separated by several days of normal stools, in contrast to constipation that may be associated with relatively infrequent hard / lumpy stools. To test this, we calculated the proportion of days with only normal consistency stools, proportion of days with only loose / watery stools, proportion of days with only hard / lumpy stools, and the proportion of days with both loose / watery and hard / lumpy stools. Th is analysis ( Table 3 ) showed that day-to-day variability in stool consistency was similar to BM-to-BM variability. Th ere were only normal stools on 39.4 % of days, only loose / watery stools on 20.1 % of days, and only hard / lumpy stools on 21.8 % of days. Both loose / watery and hard / lumpy stools were reported within the same day on 1.8 % of days. Th ere were also 16.9 % of days with no BM.
Classifi cation of IBS patients into subtypes by the Rome III Diagnostic Questionnaire compared with classifi cation based on the daily stool diary
When the Rome questionnaire was used to classify patients, the largest subgroup was IBS-M (56.2 % ) and only one patient was classifi ed as IBS-U (see last column of Table 4 ). However, when the stool diary was used to classify patients, very few met criteria for IBS-M (4.6 % ), and IBS-U became the largest group (35.4 % 
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(1.81 vs. 1.79 stools per day for men vs. women). IBS patients who were older than the median age of 35 years had signifi cantly more BMs per day than younger subjects (1.94 vs. 1.64, t = 2.185, P = 0.030), but there were no age-related diff erences in stool consistency. When the subset of 20 subjects who were aged ≥ 55 years were compared with younger subjects, no diff erences in stool consistency or stool frequency were observed. Th e frequency of fl uctuations between hard / lumpy stools and loose / watery stools was not correlated with age, sex, overall IBS severity, abdominal pain, bloating, life stress, or psychological symptoms, but a higher frequency of fl uctuation was weakly correlated with poorer IBS-QOL scores (Spearman rho = − 0.19, P = 0.009).
The association between stool consistency and other bowel symptoms
Th e symptoms of urgency, pain, and soiling were queried at each BM. When the data were combined for all IBS subtypes, loose / watery BMs were associated with more symptoms than of patients; see fi rst row of Table 4 ). Th is occurred because the Rome questionnaire overestimated the proportion of BMs that were loose / watery and the proportion that were hard / lumpy. As a consequence, patients who were classifi ed as IBS-D by the questionnaire for the most part remained IBS-D or were reclassifi ed as IBS-U based on the stool diary and, similarly, patients classifi ed as IBS-C by the questionnaire remained IBS-C or were reclassifi ed as IBS-U. Th e results of the two methods of subtyping patients were modestly but signifi cantly related ( χ 2 = 19.595; d.f. = 9; P = 0.021; Spearman rho = 0.265, P < 0.001).
Sex and age differences in stool characteristics
Women ( n = 164) had a higher proportion of BMs rated hard / lumpy compared with the 21 men (22.5 vs. 11.4 % , t = 2.727, P = 0.011), but there were no signifi cant sex diff erences in the proportion of BMs that were loose / watery (24.3 % vs. 20.0 % ), the frequency of fl uctuations between hard / lumpy and loose / watery stools (3.02 vs. 2.90 times per month), or average stool frequency Baseline value different from both fi rst month value and second month value, P < 0.001.
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hard / lumpy stools for urgency, 79.6 % vs. 28.8 % , ( P < 0.0001); for pain and discomfort, 72.9 % vs. 52.5 % ( P < 0.0001); and for soiling (incontinence), 5.2 % vs. 1.6 % ( P = 0.004).
Other bowel symptoms -abdominal pain, dissatisfaction with bowel function, interference with life activities, and bloating -were assessed retrospectively for the past 24 h at the end of each day rather than at each BM. Th ese symptoms were averaged and compared across all patients for (i) diarrhea days, defi ned as days with one or more loose / watery bowel movements but no hard / lumpy bowel movement; (ii) days with normal stool consistency; and (iii) constipation days, defi ned as days with one or more hard / lumpy bowel movements but no loose / watery bowel movements ( Figure 1 ) . Th e small number of days on which both loose / watery and hard / lumpy bowel movements occurred (average of 1.3 days per subject or 1.8 % of all diary days) were excluded from this analysis. Abdominal pain, bloating, dissatisfaction with bowel function, and interference with life activities were all rated as signifi cantly more severe during diarrhea days, whereas constipation days had signifi cantly less severe symptoms than diarrhea days but more severe symptoms than days with normal stool consistency. Table 5 compares IBS subtypes (subtype classifi cation based on Rome III Diagnostic Questionnaire) with respect to the average severity of abdominal pain, bloating, dissatisfaction with bowel habits, and interference with life activities across all days. For all four symptoms, IBS-C patients reported signifi cantly more symptom severity than IBS-D patients. Th is is contrary to what one might expect because loose / watery BMs were more frequently associated with pain and other symptoms than hard / lumpy stools ( Figure 1 ). It suggests the hypothesis that symptom distress in IBS-C patients is unrelated to the occurrence of a BM. To test this hypothesis, we compared the IBS subtypes with respect to the severity of their IBS symptoms on days when they did not have BMs. 
Association of IBS symptoms with IBS subtypes
Effects of cumulative days without a bowel movement on IBS symptoms in patients with IBS-C
Th e observation that on days with no BMs, IBS-C patients have worse symptoms than IBS-D or IBS-M patients ( Figure 2 ) suggests that, in IBS-C, symptoms may result from the cumulative distention of the bowel with stool. To test this hypothesis, we performed another post hoc test to determine whether the severity of pain and bloating increased with the cumulative number of days without a BM in patients with IBS-C. Th e data support this hypothesis: average daily pain ratings (0 -10 scale) were 4.1 aft er 1 day without a BM, 5.0 aft er 2 days with no BM, 5.7 aft er 3 days, 7.5 aft er 4 days, and 7.2 aft er 5 days. Day 1 pain ratings were signifi cantly diff erent from day 4 and day 5 by paired t -tests ( P < 0.05). Similarly, average daily bloating ratings (0 -10 scale) were 4.5 on the fi rst day without a BM, 5.6 aft er 2 days, 5.9 aft er 3 days, 6.4 aft er 4 days, and 6.3 aft er 5 days. Paired t -tests showed that day 1 bloating ratings were signifi cantly diff erent from day 5 ( P < 0.05). Th e number of IBS-C patients available for analysis were 16 for day 2, 12 for day 3, 6 for day 4, and 3 for day 5.
Differences between retrospective IBS symptom severity scores and diary-based symptom severity scores
Analysis of the diary data showed that the IBS symptoms that make up the IBS-SS diff er signifi cantly between the IBS subtypes, whereas at enrollment when subjects completed the IBS-SS retrospectively, no such diff erences between subtypes were found. 
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Individual patients have stable distributions of stool types:
the proportion of BMs that are loose / water correlates 0.783 between successive months and the proportion of BMs that are hard / lumpy correlates 0.852 between months. 4. Th e Rome III Diagnostic Questionnaire overestimates the frequency of abnormal stool types but identifi es distinct patterns of stool consistency that are correlated with symptoms. 5. Loose / watery stools are more likely than hard / lumpy stools or normal consistency stools to be accompanied by symptoms of pain, urgency, and fecal incontinence, but … . 6. Paradoxically, however, patients classifi ed as IBS-C by the Rome criteria report more abdominal pain, bloating, dissatisfaction with bowel habits, and life interference than patients meeting Rome III criteria for IBS-D because IBS-C patients have more symptoms between BMs.
Variability in stool consistency within patients
It is commonly assumed that (i) IBS-C patients have almost exclusively hard / lumpy stools or a mixture of hard / lumpy stools and stools of normal consistency, and (ii) medications that cause looser stools are indicated for chronic use in these patients, whereas these medications are not prescribed to patients with mixed stool types. Similarly, medications designed to slow colonic transit and reduce diarrhea are prescribed for chronic use in patients with IBS-D. However, our data show that 77.7 % of IBS patients fl uctuate between loose / watery stools and hard / lumpy stools, with fl uctuations occurring an average of 3 times per month. Only 10 % of IBS patients had no loose / watery stools in their diary and only 13.1 % had no hard / lumpy stools. Th ese data suggest that daily, fi xed-dose drug regimens that ignore the normal fl uctuation of stool consistency may expose patients to an increased risk of adverse events, and that " as needed " drug dosing regimens should be considered. Our fi ndings of frequent fl uctuation between loose / water stools and hard / lumpy stools in most IBS patients of all subtypes suggest that fl uctuations in stool consistency between extremes might be a defi ning general characteristic of IBS. Pimentel et al. ( 20 ) also suggested that variability in the form and frequency of stools can be used to identify IBS-D patients and distinguish them from patients with organic causes of diarrhea. However, they used a question on whether stool form and frequency vary within a day, and we found the co-occurrence of loose / watery and hard / lumpy stools within the same day to be relatively rare (1.8 % of days).
To understand this discrepancy a post hoc analysis was performed. When IBS-SS scores were computed based on diary responses and compared for the fi rst and second months of diary days, the correlation between month 1 and month 2 was r = 0.871 ( Table 2 ) . Th e correlation between scores on the baseline retrospective IBS-SS questionnaire and the diary-based IBS-SS scores, on the other hand, were lower at r = 0.618 for month 1 and r = 0.524 for month 2.
DISCUSSION
In this diary study, 185 well-characterized IBS patients provided Bristol Stool scores and other symptom ratings on consecutive BMs for an average of 73 consecutive days, yielding data on 24,642 stools. Th e principal fi ndings from this large database were as follows:
1. Th e majority (58.2 % ) of all stools are normal in consistency (Bristol Stool Scores of 3 -5). 2. Most IBS patients (77.7 % ) have both loose / watery stools and hard / lumpy stools, and they fl uctuate between these extremes an average of 3 times per month. Th ese frequent stool consistency fl uctuations occur naturally in all IBS subtypes and are not because of taking laxatives or antidiarrheal medications. 
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In view of the frequent fl uctuation of bowel habits between stool consistency extremes, one could question whether it is useful to separate IBS patients into subtypes based on the predominant stool type rather than assuming that most IBS patients will alternate and providing instruction for treatment as needed of both loose / watery and hard / lumpy stool types . However, we also found that the relative frequencies of hard / lumpy stools and loose / watery stools remain relatively constant from month to month; and that there are signifi cant diff erences in these relatively stable proportions between IBS-C and IBS-D. Th is suggests that separating IBS patients into subtypes based on stool consistency may be useful. Other investigators have also reported that IBS patients may change the subtype into which they would be placed by the Rome criteria if assessed over longer intervals of time such as 6 months to a year ( 6, 7 ) . Th ese studies used smaller periods of diary records to assess stool characteristics and may have underestimated the degree of stability.
Validation of the Rome III criteria for classifi cation of IBS patients into subtypes
Th e agreement between classifi cation of subtypes based on the retrospective Rome III Diagnostic Questionnaire and the prospective stool diary was modest ( χ 2 = 19.60; d.f. = 9; P = 0.021). Most of the discrepancies appeared to be because of an overestimation of the frequency of loose / watery and hard / lumpy stools by the Rome questionnaire. Th is is shown by the fact that patients classifi ed IBS-D by the Rome questionnaire either remained in that category when classifi ed based on the stool diary or were reclassifi ed as IBS-U because the proportion of loose / water BMs was < 25 % . Similarly, patients classifi ed IBS-C by the Rome questionnaire either retained this classifi cation or were reclassifi ed IBS-U. Th ese diff erences may be largely explained by our use of a response scale from the Rome III Diagnostic Questionnaire that asked patients whether they had loose / watery stools (or hard / lumpy stools) " sometimes " or " oft en " rather than asking them whether this occurred 25 % of the time. Patients may have not interpreted " sometimes " as the developers of the questionnaire intended. Th is problem can likely be addressed by the use of an alternative response scale for the Rome questionnaire.
Relationship between symptoms and stool consistency
We found that loose / watery bowel movements were more likely than hard / lumpy stools or normal stools to be associated with abdominal pain, urgency, and fecal soiling; and that patients reported more abdominal pain, bloating, dissatisfaction with bowel habits, and interference with activities of daily life on days when they experienced loose / watery stools as compared with days on which they experienced hard / lumpy stools or stools of normal consistency ( Figure 1 ). Th is agrees with previous reports ( 9 ) .
However, we found that the amount of symptoms associated with individual bowel movements is not a good predictor of the overall symptom burden of IBS. When all days are averaged together, patients with IBS-C (i.e., patients with chronic constipation) have signifi cantly worse abdominal pain, bloating, dissatisfaction with bowel habits, and interference with life activities than patients with IBS-D (i.e., patients with chronic diarrhea; see Table 5 ). Th is suggests that in IBS-D, bowel symptoms are triggered by defecation of loose / watery BMs, whereas in IBS-C these symptoms are temporally uncorrelated with defecation and are instead probably related to the chronic distention of the bowel with stool. Th is interpretation is supported by two post hoc analyses: when IBS-C patients were compared with IBS-D patients on days when no BMs were reported, IBS-C patients had worse symptoms on those days than patients with IBS-D ( Figure 2 ) . Moreover, daily ratings of pain and bloating become progressively more severe with the cumulative number of days IBS-C patients have gone without a BM.
Th ese observations may help clinicians to better understand and communicate with their patients regarding the diff erent eff ects of diarrhea and constipation on the patient ' s quality of life. For patients with diarrhea, it is important to focus on the characteristics of the BMs such as urgency, frequency, volume, and association with soiling; modifying these stool characteristics may bring relief. For constipated patients, on the other hand, the patient is likely to be more concerned by the chronic symptoms of bloating, pain, and tenesmus that occur throughout the day and that may not show much change with defecation. Th ese observations on possible diff erent mechanisms for symptoms in IBS-D and IBS-C also have implications for how one might design outcome assessments that are more sensitive to the mechanism of action of drugs developed to treat IBS. For patients with IBS-D and for drugs designed to control diarrhea, it may be appropriate to assess IBS symptoms at the time of defecation, whereas for patients with IBS-C and for drugs designed to relieve constipation, it may be more appropriate to emphasize daily symptom assessments that are unrelated to BMs.
Diary assessment
We also made the serendipitous observation that symptom diaries, when collected in a way that guarantees the symptom reports are made on a daily basis, provide a more sensitive and reliable method of assessing bowel symptoms than does a retrospective questionnaire. Greater sensitivity is shown by the fact that the diary data reveal signifi cant diff erences between IBS subtypes in their overall IBS-SS scores and in individual IBS symptoms, whereas the IBS-SS questionnaire given at baseline showed no diff erences between IBS subtypes. Greater reliability of the diary method is shown by the fact that measures of symptom severity show a stronger correlation between two sequential months of diary recordings (range, 0.816 -0.862) than between the baseline questionnaire and the diary assessments (range, 0.285 -0.628). Table 2 also shows that patients overestimate their pain, bloating, dissatisfaction with bowel habits, and interference with life when they respond on a questionnaire as compared with when they report these symptoms on a daily diary. As a consequence, IBS-SS total scores are signifi cantly greater for the retrospective questionnaire than for the diary method. We infer from these observations that symptom diaries are superior to retrospective questionnaires as outcome measures in treatment trials. Th e strong correlations between the fi rst and second months suggest that 1 month of diary data will be adequate for most purposes.
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about the causes of their discomfort and the goals of treatment. Th ird, we have shown that symptom diaries, collected by internet to guarantee timely reporting, are more sensitive and reliable than questionnaires or interviews for evaluating symptom severity and response to treatment.
Study strengths and limitations
Other studies have used daily symptom ratings to investigate patterns of stool consistency. However, our methodology has several advantages over comparable prior work: previous studies have generally relied on paper diaries returned to the investigator at intervals of a few weeks. In other disease states, paper diaries collected in this way are known to be vulnerable to nonadherence and recollection bias, because many subjects wait until it is time to return the diaries to the investigator and fi ll out several days retrospectively from memory or leave some days blank ( 21, 22 ) . Th is weakness of paper diaries has not been confi rmed in IBS patients, but to protect against this possibility, we required patients to report on their bowel symptoms each day via an internet website, reinforced daily completion via telephone and e-mail contact the next day for any missing days, and used only continuous series of diary records for analysis. Additionally, the length of the diary records we collected averaged 73 days in contrast to 7 days ( 23,24 ), 14 days ( 7 ), or 28 days ( 6 ) in previous studies, providing a broader picture of symptom variation. Th e reliability of the assessment of symptoms and stool consistency is refl ected by the very high degree of comparability of month 1 and month 2 data ( Table 4 ) .
Th e limitations of our study include a relatively small group of only 23 IBS-C patients. Th is small subsample limited the statistical power to assess the eff ects of cumulative days without a BM on symptoms of pain and bloating. A second limitation is that our sample was younger than usually encountered in studies of IBS (median age of 37 compared with 51 years in other studies ( 25 ) ). Th is age diff erence likely refl ects the requirement that patients should have daily internet access in order to participate. Last, we used the standard response scale in the Rome III Diagnostic Questionnaire that asks patients whether they have hard / lumpy stools (or loose / watery stools) " Never or rarely, " " Sometimes, " " Oft en, " etc. instead of the alternative response scales that ask them whether they have hard / lumpy stools " About 25 % of the time, " " About 50 % of the time, " etc. Th is likely contributed to the observed tendency for the Rome III Diagnostic Questionnaire to overestimate the frequency of hard / lumpy and loose / watery stools when a response of " sometimes " was equated with 25 % of the time. However, the method we used is the current standard form of the Rome questionnaire, and our fi nding that it substantially overestimates the amount of hard and loose stools suggests that alternative wording may be needed to subtype IBS.
Summary
We made three key observations that have implications for clinical practice: fi rst, the fi nding that ¾ of IBS patients fl uctuate between the extremes of loose / watery stools and hard / lumpy stools suggests that medications that target diarrhea or constipation may produce fewer side eff ects and greater patient satisfaction if dosed " as needed " rather than on a fi xed dose. Second, we found that diff erent mechanisms appear to be responsible for pain and other bowel symptoms in diarrhea (defecation-related sensations) vs. constipation (cumulative distention of the bowel). Th is insight may improve our ability to communicate with patients
